Who Owns CRBP?

Corbus Pharmaceuticals Holdings, Inc. — Institutional Ownership & 13F Holdings

$9.84

-0.24 (-2.38%)

Market Cap

$119.7M

Shares Outstanding

12,535,503

Institutional Holders

85

Total Inst. Value

$59.5M

% of Float Held

QoQ Holder Change

+17

Institutional data as of Q1 2025

New Positions

18

Closed Positions

31

Increased

26

Decreased

23

Institutional Ownership Trend

Top 10 Institutional Holders(Q1 2025)

#FundValueShares
1Cormorant Asset Management, LP$12.6M2,375,000
2Octagon Capital Advisors LP$10.7M3,552,000
3ORBIMED ADVISORS LLC$6.2M1,172,287
4BlackRock, Inc.$4.5M846,062
5VANGUARD GROUP INC$3.6M672,057
6Prosight Management, LP$3.1M575,136
7RENAISSANCE TECHNOLOGIES LLC$1.8M345,200
8Exome Asset Management LLCNew$1.5M289,690
9GEODE CAPITAL MANAGEMENT, LLC$1.4M271,514
10ARMISTICE CAPITAL, LLC$1.3M250,000

Biggest Buyers & Sellers This Quarter

Top Buyers

Famous Fund Managers

Related Stocks

Frequently Asked Questions

How many institutional investors hold CRBP?

As of Q1 2025, 85 institutional investors report holding CRBP (Corbus Pharmaceuticals Holdings, Inc.) in their 13F filings.

Which hedge fund owns the most CRBP?

The largest institutional holder of CRBP is Cormorant Asset Management, LP with $12.6M in shares.

Are institutions buying or selling CRBP?

This quarter, 18 institutions opened new positions in CRBP and 31 closed their positions.

What is 13F institutional ownership?

SEC Form 13F is a quarterly report filed by institutional investment managers with over $100M in qualifying assets. It discloses their US equity holdings, providing transparency into what the largest investors are buying and selling.

How often is institutional ownership data updated?

13F filings are due 45 days after each calendar quarter end (May 15, Aug 14, Nov 14, Feb 14). Data is updated on HedgeTrace as new filings are processed.